慢性右心力衰竭和三回的评估和管理原则
Revathy Sampath-Kumar1, Andreas Rück2,3, Aristomenis Manouras2,3
1Department of Cardiovascular Medicine, University of California, La Jolla, San Diego, CA, USA.
Current heart failure reports
|October 27, 2025
概括
慢性右心力衰竭和三腹反往往并存,影响患者的结果. 诊断和跨导管三门干预的进展为选定的患者提供了新的管理策略.
科学领域:
- 心脏病学 心脏病学
- 心血管医学 心血管医学
- 心脏衰竭研究研究
背景情况:
- 慢性右心力衰竭 (RHF) 和三回 (TR) 是常见的,复杂的疾病,具有显著的发病率和死亡率.
- RHF和TR之间的关系是双向的,TR加剧了RHF,RHF促进了TR的进展.
研究的目的:
- 提供对慢性RHF和TR的评估和管理的最新审查.
- 专注于不断发展的诊断方法和跨导管三门干预 (TTVI) 的作用.
主要方法:
- 审查关于RHF和TR的当前文献.
- 分析诊断成像技术的进步,包括3D心声学和心脏磁共振.
- 评估TTVI在患者管理中的新兴作用.
主要成果:
- 改进的成像方式提高了对右心室功能和TR严重性的评估.
- 新的TR分级类别 (大规模,洪流) 允许更精确的分类.
- 跨导管三门干预 (TTVI) 为特定患者提供了一种新的治疗选择,尽管最佳选择和时间仍然具有挑战性.
结论:
- 早期识别和全面管理RHF和TR对于优化结果至关重要.
- 多学科的心脏团队方法和风险分层是必不可少的.
- 需要进一步的研究来完善TTVI的选择标准和时间.
相关概念视频
Mitral Regurgitation IV: Nursing Management
300
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
300
Mitral Regurgitation I: Introduction
402
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
402
Mitral Regurgitation III: Medical Management
268
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
268
Rheumatic Heart Disease III: Medical Management
278
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
278
Aortic Regurgitation III: Medical Management
388
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
388
Mitral Valve Prolapse II: Assessment and Management
406
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
406


